New World Medical Launches Implant to Treat Moderate and Severe Glaucoma

New World Medical is launching an implant that would give patients an additional option for treatment of moderate to severe glaucoma. The Ahmed ClearPath device, named after the Rancho Cucamonga, CA-based company’s founder Dr. A. Mateen Ahmed, helps drain intraocular pressure in patients. The Ahmed ClearPath is available in two sizes, 350 mm2 and 250 mm2. Designed with convenience in mind, the two sizes address some of the surgeon's toughest challenges in tube shunt surgery, a procedure that lowers the pressure inside the eye for refractory glaucoma. New World Medical’s Chief Commercial Officer, Rafael Chan, said the technology differs from micro-invasive glaucoma surgery (MIGS) offerings such as Glaukos’ iStent. “Typically, the MIGS device or procedures are reserved for mild to moderate [glaucoma cases],” Chan, told MD+DI. “In not all, but many cases those are combined with cataract surgery. The ClearPath implant doesn’t compete with the MIGS procedures.” One feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. In addition, the suture fixation points are positioned more anteriorly on the device compared to other valveless drainage devices. By making the suture points more visible and accessible, the company said the surgeon may find securing this implant to the e...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Business Source Type: news